<DOC>
	<DOCNO>NCT00897754</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor understand patient respond treatment . PURPOSE : This laboratory study look gene expression patient advance metastatic colorectal cancer receive bevacizumab .</brief_summary>
	<brief_title>Gene Expression Patients With Advanced Metastatic Colorectal Cancer Receiving Bevacizumab</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether balance splice form expression alters susceptibility tumor vivo respond anti-VEGF therapy . OUTLINE : Tumor tissue sample collect clinical trial E-3200 analyze laboratory endpoint .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Tumor tissue sample available patient advance metastatic adenocarcinoma colon rectum Receiving bevacizumab clinical trial E3200 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
</DOC>